Journals / Selçuk Tıp Dergisi / 2021 / Cilt: 37 - Sayı: 2

The Predictive Value of Free PSA/PSAD, (F/T)/PSAD in Detect of Prostate Cancer Between PSA Values 4-10 ng/ml: A Single-Center Study Results

PSA Değeri 4-10 Arasında Olan Hastalarda Prostat Kanserini Öngörmede Serbest PSA/PSAD, (Serbest/Total PSA)/PSAD' nin Tanısal Değeri; Tek Merkezli Çalışma Sonuçları

Pages
106–112
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, more research is needed to evaluate the ef ficiency of predictive value of these parameters.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The present study aimed to investigate the predictive value of (F/T)/PSAD and Free PSA/PSAD in PCa detection in Turkish males.
📊
Key Findings & Data:Patients and Methods: A retrospective analysis of patients’ files, from January 2007 to December 2017, with prostate-specific antigen (PSA) values between 4-10 ng/ml was conducted.
💡
Conclusion & Impact:However, more research is needed to evaluate the ef ficiency of predictive value of these parameters.
🔬Design:Modeling & Simulation
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

The present study aimed to investigate the predictive value of (F/T)/PSAD and Free PSA/PSAD in PCa detection in Turkish males. Patients and Methods: A retrospective analysis of patients’ files, from January 2007 to December 2017, with prostate-specific antigen (PSA) values between 4-10 ng/ml was conducted. According to the prostate biopsy outcomes, data were collected from patients and divided into prostate cancer (PCa) and/or benign prostatic hyperplasia (BPH) groups. Among the groups, prostate volume (PV), Free PSA (FPSA), Total PSA (TPSA), free-to-total PSA ratio (F/T), PSA Density (PSAD), (F/T)/PSAD, and FPSA/PSAD values were evaluated and compared. The utilization of these values in PCa detection was examined. Results: The present study participants were 131 PCa and 196 BPH patients, 327 in total. Sensitivity and specificity values of (F/T)/PSAD and FPSA/PSAD were better than PSAD, PSA, F/T. According to the optimal cut-off value, the sensitivity of (F/T)/PSAD and FPSA/PSAD was similar. Likewise, NPV of F/T, (F/T)/PSAD, and FPSA/PSAD were also similar. The logistic regression model using a combination of age, PV, FPSA/PSAD, and (F/T)/PSAD displayed a higher AUC than each of these values per se. Conclusion: FPSA/PSAD and (F/T)/PSAD, the relatively new parameters, have similar predictive accuracy in PCa detection. They have higher sensitivity and specificity than F/T PSA and PSAD alone. However, more research is needed to evaluate the ef ficiency of predictive value of these parameters.

Özet

Bu çalışmada, Türk popülasyonunda prostat kanseri tespiti için (Serbest/Toplam PSA)/PSAD ve FPSA/PSAD' nın tanısal değerini araştırmayı amaçladık. Hastalar ve Yöntem: Ocak 2007-Aralık 2017 tarihleri arasında prostat spesifik antijen (PSA) değerleri 4-10 ng/ml arasında olan hastaların dosyaları retropesktif olarak incelendi. Veriler prostat biyopsi sonuçlarına göre prostat kanseri (PCa) ve benign prostat hiperplazisi (BPH) gruplarına ayrılan hastalardan toplandı. Gruplar arasında prostat hacmi (PV), Serbest PSA (FPSA), Total PSA (TPSA), serbest-total PSA oranı (F/T), PSA Yoğunluğu (PSAD), (F/T)/PSAD ve FPSA/PSAD gibi değerler kaydedildi ve karşılaştırıldı. Bu değerlerin prostat kanserini öngörmede kullanılabilirliği incel endi. Bulgular: Çalışmaya toplam 327 hasta (131 PCa ve 196 BPH) dahil edildi. (F/T)/PSAD ve FPSA/PSAD' nin duyarlılık ve özgüllük değerleri PSAD, PSA, F/T'den daha iyiydi. Optimum kesme değerine bağlı olarak, (F/T)/PSAD ve FPSA/PSAD' nin duyarlılığı benzerdi. F/T, (F/T)/PSAD ve FPSA/PSAD' nin negatif öngörü değerleri benzerdi. Yaş, PV, FPSA/PSAD ve (F/T)/PSAD kombinasyonunu kullanan lojistik regresyon modeli, tek başına her birinden daha yüksek AUC gösterdi. Sonuç: Nispeten yeni parametreler olan FPSA/PSAD ve (F/T)/PSAD prostat kanserini ön görmede benzer teşhis doğruluğuna sahiptir parametrelerdir. İncelenen bu iki parametre, F/T ve tek başına PSAD' den daha yüksek duyarlılığa ve özgüllüğe sahiptir. Bununla birlikte, bu parametrelerin tanısal değerinin etkinliğini değerlendirmek için daha fazla araştırmaya ihtiyaç vardır.

🔖

Cite This Article

Iyisoy, S., Goger, Y. E., Ozkent, M. S., Karalezli, G., Kılınc, M. (2022). The Predictive Value of Free PSA/PSAD, (F/T)/PSAD in Detect of Prostate Cancer Between PSA Values 4-10 ng/ml: A Single-Center Study Results. Selçuk Tıp Dergisi, Cilt: 37 - Sayı: 2, 106–112. https://ajindex.com/articles/591795

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Bakanlığı S. Sağlık İstatistikleri Yıllığı 2016 Haber Bülteni. Sağlık Araştırmaları Genel Müdürlüğü, Ankara. 2017.
  2. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994;151(5):1283-90.
  3. Stamey TA, Caldwell M, McNEAL JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? J Urol 2004;172(4 Part 1):1297-301.
  4. Shariat SF, Roehrborn CG. Using biopsy to detect prostate cancer. Rev Urol 2008;10(4):262. Sarwar S, Adil MAM, Nyamath P, et al. Biomarkers of prostatic cancer: An attempt to categorize patients into prostatic carcinoma, benign prostatic hyperplasia, or prostatitis based on serum prostate specific antigen, prostatic acid phosphatase, calcium, and phosphorus. Prostate Cancer 2017;2017:5687212. Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men. J Urol 2000;163(4):1144-9.
  5. Matsuyama H, Baba Y, Yamakawa GI, et al. Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer. Int J Urol 2000;7(11):409-14.
  6. Yilmaz H, Ciftci S, Yavuz U, et al. Percentage of free prostatespecific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values. Kaohsiung J Med Sci 2015;31(6):315-9.
  7. Veneziano S, Pavlica P, Compagnone G, et al. Usefulness of the (F/T)/PSA density ratio to detect prostate cancer. Urol Int 2005;74(1):13-8.
  8. Yan D, Hu E, Zhang H, et al. The significance of PSA modified parameters (F/T)/PSAD for diagnosing prostatic cancer in the grey zone of 4~10 ng/ml. Chinese J Clin Oncol 2007;4(5):347-50.
  9. Nan L-B, Yin X-T, Gao J-P. Significant diagnostic value of free-serum PSA (FPSA)/prostate-specific antigen density (PSAD) and (F/T)/PSAD for prostate cancer of the chinese population in a single institution. Med Sci Monit: Int Med J Exper Clin Res 2019;25:8345. Guazzoni G, Nava L, Lazzeri M, et al. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: Results of a prospective study in a clinical setting. Eur Urol 2011;60(2):214-22.
  10. Loeb S, Sokoll LJ, Broyles DL, et al. Prospective multicenter ev